BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18588458)

  • 1. Intraperitoneal chemotherapy: standard of care for patients with minimal residual stage III ovarian cancer?
    Tummala MK; Alagarsamy S; McGuire WP
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1135-47. PubMed ID: 18588458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
    Almadrones L
    Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraperitoneal chemotherapy for ovarian cancer].
    Noma J; Yoshida N
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraperitoneal chemotherapy in ovarian carcinoma].
    Piura B
    Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
    Ferron G; Martinez A; Mery E; Querleu D; Thomas F; Chatelut E; Gladieff L
    Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
    Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
    Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy supporting the role of intraperitoneal drug delivery in the primary chemotherapeutic management of small-volume residual advanced ovarian cancer.
    Markman M
    Semin Oncol; 2006 Dec; 33(6 Suppl 12):S3-7. PubMed ID: 17223444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside.
    de Bree E; Theodoropoulos PA; Rosing H; Michalakis J; Romanos J; Beijnen JH; Tsiftsis DD
    Cancer Treat Rev; 2006 Oct; 32(6):471-82. PubMed ID: 16942841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer.
    Sugarbaker PH
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):15-24. PubMed ID: 19124999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ovarian cancer with intraperitoneal chemotherapy.
    Hydzik C
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):15-20. PubMed ID: 19856603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
    Royer B; Delroeux D; Guardiola E; Combe M; Hoizey G; Montange D; Kantelip JP; Chauffert B; Heyd B; Pivot X
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigational agents for epithelial ovarian cancer.
    Muggia F; Kosloff R
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):855-68. PubMed ID: 16221055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological bases of intraperitoneal chemotherapy].
    Gladieff L; Chatelut E; Dalenc F; Ferron G
    Bull Cancer; 2009 Dec; 96(12):1235-42. PubMed ID: 19923051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal chemotherapy: a reemerging approach in the treatment of ovarian cancer.
    Drake B
    J Infus Nurs; 2009; 32(6):314-22. PubMed ID: 19918140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment.
    Muggia FM
    Semin Oncol; 2006 Dec; 33(6 Suppl 12):S18-24. PubMed ID: 17223446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal chemotherapy in the management of malignant disease.
    Markman M
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer.
    Markman M
    Cancer J; 2009; 15(2):105-9. PubMed ID: 19390303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Report of nationwide questionnaire: intraperitoneal chemotherapy for advanced ovarian cancer based on clinical results--reports of 5th "Gynecologic Intraperitoneal Chemotherapy Study Group" meeting].
    Umezawa S; Shimizu Y; Takizawa K; Nishimura H; Hatae M; Sasaki K; Yoshikawa H
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1305-11. PubMed ID: 8831743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
    Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.